Trials / Not Yet Recruiting
Not Yet RecruitingNCT04875234
Vision Improvement for Legally Blind Dry AMD Patients
Vision Improvement for Legally Blind Dry Age-Related Macular Degeneration Patients
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Optimal Acuity Corporation · Industry
- Sex
- All
- Age
- 50 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
This retrospective observational study is intended to assess the feasibility of using a nonsignificant risk device for vision improvement for legally blind dry AMD patients.
Detailed description
This retrospective observational study is intended to assess the feasibility of using a nonsignificant risk device for vision improvement for legally blind dry Age-Related Macular Degneration patients. 12-month follow-up examinations will be used to assess the amount of vision improvement and its dependence on device parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Clear-K Low Vision Aid Treatment | A Clear-K Low Vision Aid Device is used to produce small corneal shape and refraction changes in order to redirect light onto functional areas of the retina. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2025-07-01
- Completion
- 2026-12-01
- First posted
- 2021-05-06
- Last updated
- 2023-03-22
Source: ClinicalTrials.gov record NCT04875234. Inclusion in this directory is not an endorsement.